List of Tables

    Table 1. Global Engineered T Cells Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Tumor Infiltrating Lymphocytes

    Table 3. Key Players of T Cell Receptor {TCR}

    Table 4. Key Players of Chimeric Antigen Receptor(CAR)

    Table 5. Global Engineered T Cells Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Engineered T Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Engineered T Cells Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Engineered T Cells Market Share by Region (2019-2024)

    Table 9. Global Engineered T Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Engineered T Cells Market Share by Region (2025-2030)

    Table 11. Engineered T Cells Market Trends

    Table 12. Engineered T Cells Market Drivers

    Table 13. Engineered T Cells Market Challenges

    Table 14. Engineered T Cells Market Restraints

    Table 15. Global Engineered T Cells Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Engineered T Cells Market Share by Players (2019-2024)

    Table 17. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)

    Table 18. Ranking of Global Top Engineered T Cells Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Engineered T Cells Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Engineered T Cells Product Solution and Service

    Table 22. Date of Enter into Engineered T Cells Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Engineered T Cells Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Engineered T Cells Revenue Market Share by Type (2019-2024)

    Table 26. Global Engineered T Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Engineered T Cells Revenue Market Share by Type (2025-2030)

    Table 28. Global Engineered T Cells Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Engineered T Cells Revenue Market Share by Application (2019-2024)

    Table 30. Global Engineered T Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Engineered T Cells Revenue Market Share by Application (2025-2030)

    Table 32. North America Engineered T Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Engineered T Cells Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Engineered T Cells Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Engineered T Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Engineered T Cells Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Engineered T Cells Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Engineered T Cells Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Engineered T Cells Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Engineered T Cells Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Engineered T Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Engineered T Cells Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Engineered T Cells Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Engineered T Cells Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Engineered T Cells Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Engineered T Cells Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Autolus Limited Company Detail

    Table 48. Autolus Limited Business Overview

    Table 49. Autolus Limited Engineered T Cells Product

    Table 50. Autolus Limited Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 51. Autolus Limited Recent Development

    Table 52. Bellicum Pharmaceuticals Company Detail

    Table 53. Bellicum Pharmaceuticals Business Overview

    Table 54. Bellicum Pharmaceuticals Engineered T Cells Product

    Table 55. Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 56. Bellicum Pharmaceuticals Recent Development

    Table 57. Cells Medica Company Detail

    Table 58. Cells Medica Business Overview

    Table 59. Cells Medica Engineered T Cells Product

    Table 60. Cells Medica Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 61. Cells Medica Recent Development

    Table 62. Elli Lilly and Company Company Detail

    Table 63. Elli Lilly and Company Business Overview

    Table 64. Elli Lilly and Company Engineered T Cells Product

    Table 65. Elli Lilly and Company Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 66. Elli Lilly and Company Recent Development

    Table 67. Gilead Sciences Company Detail

    Table 68. Gilead Sciences Business Overview

    Table 69. Gilead Sciences Engineered T Cells Product

    Table 70. Gilead Sciences Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 71. Gilead Sciences Recent Development

    Table 72. Juno Therapeutics Company Detail

    Table 73. Juno Therapeutics Business Overview

    Table 74. Juno Therapeutics Engineered T Cells Product

    Table 75. Juno Therapeutics Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 76. Juno Therapeutics Recent Development

    Table 77. Novartis Company Detail

    Table 78. Novartis Business Overview

    Table 79. Novartis Engineered T Cells Product

    Table 80. Novartis Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 81. Novartis Recent Development

    Table 82. Oxford Biomedica Company Detail

    Table 83. Oxford Biomedica Business Overview

    Table 84. Oxford Biomedica Engineered T Cells Product

    Table 85. Oxford Biomedica Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 86. Oxford Biomedica Recent Development

    Table 87. Pfizer Company Detail

    Table 88. Pfizer Business Overview

    Table 89. Pfizer Engineered T Cells Product

    Table 90. Pfizer Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 91. Pfizer Recent Development

    Table 92. Precision Bioscience Company Detail

    Table 93. Precision Bioscience Business Overview

    Table 94. Precision Bioscience Engineered T Cells Product

    Table 95. Precision Bioscience Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 96. Precision Bioscience Recent Development

    Table 97. Redmile Group Company Detail

    Table 98. Redmile Group Business Overview

    Table 99. Redmile Group Engineered T Cells Product

    Table 100. Redmile Group Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 101. Redmile Group Recent Development

    Table 102. Seeking Alpha Company Detail

    Table 103. Seeking Alpha Business Overview

    Table 104. Seeking Alpha Engineered T Cells Product

    Table 105. Seeking Alpha Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 106. Seeking Alpha Recent Development

    Table 107. Unum Therapeutics Company Detail

    Table 108. Unum Therapeutics Business Overview

    Table 109. Unum Therapeutics Engineered T Cells Product

    Table 110. Unum Therapeutics Revenue in Engineered T Cells Business (2019-2024) & (US$ Million)

    Table 111. Unum Therapeutics Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Engineered T Cells Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Engineered T Cells Market Share by Type: 2023 VS 2030

    Figure 3. Tumor Infiltrating Lymphocytes Features

    Figure 4. T Cell Receptor {TCR} Features

    Figure 5. Chimeric Antigen Receptor(CAR) Features

    Figure 6. Global Engineered T Cells Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Engineered T Cells Market Share by Application: 2023 VS 2030

    Figure 8. Hospitals Case Studies

    Figure 9. Cancer Research Centers Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Engineered T Cells Report Years Considered

    Figure 12. Global Engineered T Cells Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Engineered T Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Engineered T Cells Market Share by Region: 2023 VS 2030

    Figure 15. Global Engineered T Cells Market Share by Players in 2023

    Figure 16. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Engineered T Cells as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Engineered T Cells Revenue in 2023

    Figure 18. North America Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Engineered T Cells Market Share by Country (2019-2030)

    Figure 20. United States Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Engineered T Cells Market Share by Country (2019-2030)

    Figure 24. Germany Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Engineered T Cells Market Share by Region (2019-2030)

    Figure 32. China Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Engineered T Cells Market Share by Country (2019-2030)

    Figure 40. Mexico Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Engineered T Cells Market Share by Country (2019-2030)

    Figure 44. Turkey Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Engineered T Cells Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Autolus Limited Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 47. Bellicum Pharmaceuticals Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 48. Cells Medica Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 49. Elli Lilly and Company Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 50. Gilead Sciences Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 51. Juno Therapeutics Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 52. Novartis Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 53. Oxford Biomedica Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 54. Pfizer Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 55. Precision Bioscience Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 56. Redmile Group Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 57. Seeking Alpha Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 58. Unum Therapeutics Revenue Growth Rate in Engineered T Cells Business (2019-2024)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed